This tender invites qualified suppliers to provide a comprehensive range of pathology laboratory reagents and consumables for the financial year 2026-27. The procurement covers multiple categories including hematology, microbiology, chemistry, stains and solutions, blood bank antibodies, and PCR molecular kits. The scope includes items from reputed brands such as Siemens, Sigma, Bio-Rad, Merck, and others, ensuring high-quality laboratory diagnostics materials. The supply will support advanced diagnostic services with reagents for manual and automated testing, culture media, biochemical kits, antibodies, and molecular amplification kits. These materials are essential for accurate and timely laboratory results, critical for patient care and research. The tender emphasizes the need for authorized distributors and pre-qualified brands to maintain quality standards. Bidders should ensure compliance with PEC registration requirements relevant to medical supplies and maintain an active FBR ATL status for the fiscal year 2025-26. Earnest Money in the form of a Call Deposit Receipt (CDR) is mandatory, and the tender validity period aligns with the financial year 2026-27. Suppliers must be prepared to submit both technical and financial bids, adhering to all regulatory and procedural guidelines. The submission deadline is set for the end of June 2024, with bids to be opened promptly thereafter. Interested parties should deliver sealed bids to the designated office address as specified in the tender documents. It is crucial to follow the submission method strictly to avoid disqualification. Pro-Tip: Carefully review the tender advertisement for specific Earnest Money and stamp duty requirements, as these are often overlooked and can lead to bid rejection. Also, verify the authenticity of brand authorization certificates to ensure eligibility.